Neonatal developmental and epileptic encephalopathy with movement disorder and arthrogryposis: A shared phenotype across brain‐expressed sodium channelopathies
Epilepsia · 2026
DOI: 10.1002/epi.70220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Sopio Gverdtsiteli und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, Member of the European Reference Network EpiCARE, Dianalund, Denma…. Hauptthemen laut MEDLINE: Arthrogryposis, Channelopathies, Movement Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Neuroscience Academy Denmark (Lundbeck Foundation).
Abstract (Originalsprache)
Objective
Neonatal developmental and epileptic encephalopathy with movement disorder and arthrogryposis (NDEEMA) represents the most severe end of the gain‐of‐function (GOF) SCN1A disorder spectrum. Sporadic cases of congenital arthrogryposis have also been reported in individuals with SCN2A‐ , SCN3A‐, and SCN8A ‐related developmental and epileptic encephalopathy. Here, we investigated whether NDEEMA occurs in other brain‐expressed sodium channelopathies and characterized its features.
Methods
Individuals with the clinical phenotype of NDEEMA were identified through internal databases, an international network of epileptologists and geneticists, and the literature. Their clinical and genetic information was analyzed. A literature survey was conducted to review studies describing the functional effects of the pathogenic variants.
Results
Of 46 NDEEMA individuals, 25 harbored variants in SCN1A , 13 in SCN2A , one in SCN3A, and seven in SCN8A . Thirty‐five different pathogenic/likely pathogenic missense variants were identified, all of which clustered in evolutionary conserved paralogous Na V positions. Five individuals died in utero. Thirty‐nine of 41 (95%) liveborn individuals developed neonatal epilepsy with tonic seizures and/or apnea. Thirty‐one individuals tried sodium channel blockers, of whom 21 (68%) experienced seizure reduction. All individuals for whom information was available developed movement disorders, with myoclonus, dystonia, and tremor being the most common features. Literature review of functional studies revealed that nine NDEEMA variants, and the corresponding paralogues of 16 additional NDEEMA variants, have been biophysically characterized as GOF. Significance This study expands the phenotype of NDEEMA from SCN1A to its paralogue sodium channel genes expressed in the brain: SCN2A, SCN3A , and SCN8A .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, Member of the European Reference Network EpiCARE, Dianalund, Denmark.
- Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
- Department of Neurology, University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Neuroscience and Medical Genetics Department, Meyer Children's Hospital IRCCS, Florence, Italy.
- University of Florence, Florence, Italy.
- Division of Pediatric Neurology, Dr. von Haunersches Children's Hospital, Ludwig-Maximilian University (LMU) Munich, Munich, Germany.
ORCID-Profile: Sopio Gverdtsiteli, Francesca Furia, Carmen Barba, Ingo Borggraefe, Roberto Caraballo, Katrin Ounap, Konrad Platzer, Alfonso Represa, Carl E Stafstrom, Kette D Valente, Elena Gardella, Andreas Brunklaus, Rikke S Møller
Förderung
- Neuroscience Academy Denmark (Lundbeck Foundation)
Zitieren
APA
Gverdtsiteli, S., Ortiz, S., Brünger, T., Furia, F., Barba, C., Bjørg-Hammer, T., Borggraefe, I., Caraballo, R., Cirak, S., Espeche, A., Fazeli, W., Guerrini, R., Juanes, M., Kassahn, K., Kinali, M., Krämer, J., Kröll, J., Herrero, M. C. M., Oegema, R., …, & Møller, R. S. (2026). Neonatal developmental and epileptic encephalopathy with movement disorder and arthrogryposis: A shared phenotype across brain‐expressed sodium channelopathies. Epilepsia. https://doi.org/10.1002/epi.70220
Vancouver
Gverdtsiteli S, Ortiz S, Brünger T, Furia F, Barba C, Bjørg-Hammer T, et al. Neonatal developmental and epileptic encephalopathy with movement disorder and arthrogryposis: A shared phenotype across brain‐expressed sodium channelopathies. Epilepsia. 2026. doi:10.1002/epi.70220
BibTeX
@article{Gverdtsiteli2026,
author = {Gverdtsiteli, Sopio and Ortiz, Sebastian and Brünger, Tobias and Furia, Francesca and Barba, Carmen and Bjørg-Hammer, Trine and Borggraefe, Ingo and Caraballo, Roberto and Cirak, Sebahattin and Espeche, Alberto and Fazeli, Walid and Guerrini, Renzo and Juanes, Matias and Kassahn, Karin and Kinali, Maria and Krämer, Johannes and Kröll, Judith and Herrero, Maria Concepción Miranda and Oegema, Renske and Ounap, Katrin and Peñuela, Oscar and Platzer, Konrad and Prasad, Asuri Narayan and Pujol, Aurora and Reinson, Karit and Represa, Alfonso and Roza, Eugenia and Valenzuela, Gabriela Reyes and Rodríguez-Palmero, Agustí and Sallevelt, Suzanne and Sanchez-Albiusa, Maria Iciar and Scheffer, Ingrid E and Smid, Cory and Stafstrom, Carl E and Stattin, Eva-Lena and Suarez, Jen R and Syrbe, Steffen and Valente, Kette D and Wagner, Matias and Wortmann, Saskia and Gardella, Elena and Lal, Dennis and Brunklaus, Andreas and Møller, Rikke S},
title = {Neonatal developmental and epileptic encephalopathy with movement disorder and arthrogryposis: A shared phenotype across brain‐expressed sodium channelopathies},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70220}
}
EUVIMED